Il 1 Blocking Agents + Rilonacept Interaction
Majorinteraction on record
Description
Concomitant administration not recommended due to potential for pharmacologic interactions and increased risk of serious toxicities.
Mechanism
Potential pharmacologic interaction between rilonacept and other IL-1 blocking agents
Source: NLP:rilonacept